R. Mark Adams, Chief Operating Officer at Adaptive Biotechnologies Corp (ADPT), sold 3,125 shares at $8.63 ($27K) on 2023-04-11, disclosed to the SEC on 2023-04-12.
Scheduled sale ($27k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.50 | 817 | $7K | 25.9% |
| 2 | $8.63 | 2,308 | $20K | 74.1% |
| Total | $8.60 avg | 3,125 | $27K | 100% |
| Filing → |
| ADPT | SELL | 2022-10-11 | $23K | — | Filing → |
| ADPT | SELL | 2022-07-08 | $32K | — | Filing → |
| ADPT | SELL | 2022-04-08 | $11K | — | Filing → |